Sam Klempner, Associate Professor at Harvard Medical School, shared on X:
“Always fun to write with Raghav Sundar. In Med by Cell Press.”
Title: Reprogramming HER2-Positive gastroesophageal cancer immune contexture with bispecific therapy: HERIZON-GEA-01
Authors: Raghav Sundar, Samuel J. Klempner
You can also read:
HERIZON-GEA-01 Updates: Zanidatamab ± Tislelizumab in HER2-Positive Gastroesophageal Cancer
